Does the media prefer AVAH or HIMS?

In the previous week, Hims & Hers Health had 14 more articles in the media than Aveanna Healthcare. MarketBeat recorded 19 mentions for Hims & Hers Health and 5 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 1.03 beat Hims & Hers Health's score of 0.45 indicating that Aveanna Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aveanna Healthcare 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 7 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer AVAH or PACS?

In the previous week, Aveanna Healthcare had 3 more articles in the media than PACS Group. MarketBeat recorded 5 mentions for Aveanna Healthcare and 2 mentions for PACS Group. Aveanna Healthcare's average media sentiment score of 1.03 beat PACS Group's score of 0.40 indicating that Aveanna Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aveanna Healthcare 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PACS Group 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer BLLN or AVAH?

In the previous week, Aveanna Healthcare had 2 more articles in the media than Billiontoone. MarketBeat recorded 5 mentions for Aveanna Healthcare and 3 mentions for Billiontoone. Aveanna Healthcare's average media sentiment score of 1.03 beat Billiontoone's score of 0.63 indicating that Aveanna Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Billiontoone 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aveanna Healthcare 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer CELC or AVAH?

In the previous week, Celcuity had 6 more articles in the media than Aveanna Healthcare. MarketBeat recorded 11 mentions for Celcuity and 5 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 1.03 beat Celcuity's score of -0.01 indicating that Aveanna Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 3 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Aveanna Healthcare 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor SHC or AVAH?

In the previous week, Sotera Health had 2 more articles in the media than Aveanna Healthcare. MarketBeat recorded 7 mentions for Sotera Health and 5 mentions for Aveanna Healthcare. Sotera Health's average media sentiment score of 1.25 beat Aveanna Healthcare's score of 1.03 indicating that Sotera Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sotera Health 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aveanna Healthcare 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Aveanna Healthcare (AVAH) Competitors

$9.45 +0.37 (+4.07%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$9.57 +0.12 (+1.27%)

As of 07/24/2026 07:34 PM Eastern

Compare

AVAH vs. HIMS, PACS, BLLN, CELC, and SHC

Should you buy Aveanna Healthcare stock or one of its competitors? MarketBeat compares Aveanna Healthcare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aveanna Healthcare include Hims & Hers Health (HIMS), PACS Group (PACS), Billiontoone (BLLN), Celcuity (CELC), and Sotera Health (SHC). These companies are all part of the "healthcare" industry.

How does Aveanna Healthcare compare to Hims & Hers Health?

Aveanna Healthcare (NASDAQ:AVAH) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, media sentiment, institutional ownership and valuation.

In the previous week, Hims & Hers Health had 14 more articles in the media than Aveanna Healthcare. MarketBeat recorded 19 mentions for Hims & Hers Health and 5 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 1.03 beat Hims & Hers Health's score of 0.45 indicating that Aveanna Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aveanna Healthcare	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	7 Very Positive mention(s)	0 Positive mention(s)	8 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral

88.0% of Aveanna Healthcare shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 5.3% of Aveanna Healthcare shares are held by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Aveanna Healthcare has a beta of 1.89, suggesting that its stock price is 89% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.35, suggesting that its stock price is 135% more volatile than the broader market.

Aveanna Healthcare presently has a consensus price target of $10.78, indicating a potential upside of 14.05%. Hims & Hers Health has a consensus price target of $31.43, indicating a potential upside of 11.85%. Given Aveanna Healthcare's stronger consensus rating and higher probable upside, research analysts clearly believe Aveanna Healthcare is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19

Aveanna Healthcare has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aveanna Healthcare	$2.43B	0.85	$225.03M	$1.18	8.01
Hims & Hers Health	$2.37B	2.74	$128.37M	-$0.09	N/A

Aveanna Healthcare has a net margin of 10.37% compared to Hims & Hers Health's net margin of -0.56%. Aveanna Healthcare's return on equity of 124.68% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aveanna Healthcare	10.37%	124.68%	7.07%
Hims & Hers Health	-0.56%	6.10%	1.52%

Summary

Aveanna Healthcare beats Hims & Hers Health on 13 of the 17 factors compared between the two stocks.

How does Aveanna Healthcare compare to PACS Group?

Aveanna Healthcare (NASDAQ:AVAH) and PACS Group (NYSE:PACS) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, earnings, valuation, institutional ownership, analyst recommendations, dividends and risk.

88.0% of Aveanna Healthcare shares are owned by institutional investors. 5.3% of Aveanna Healthcare shares are owned by company insiders. Comparatively, 70.1% of PACS Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Aveanna Healthcare currently has a consensus target price of $10.78, suggesting a potential upside of 14.05%. PACS Group has a consensus target price of $50.60, suggesting a potential upside of 8.28%. Given Aveanna Healthcare's higher probable upside, analysts clearly believe Aveanna Healthcare is more favorable than PACS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

Aveanna Healthcare has a net margin of 10.37% compared to PACS Group's net margin of 4.49%. Aveanna Healthcare's return on equity of 124.68% beat PACS Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aveanna Healthcare	10.37%	124.68%	7.07%
PACS Group	4.49%	26.47%	4.36%

Aveanna Healthcare has a beta of 1.89, meaning that its share price is 89% more volatile than the broader market. Comparatively, PACS Group has a beta of -0.08, meaning that its share price is 108% less volatile than the broader market.

In the previous week, Aveanna Healthcare had 3 more articles in the media than PACS Group. MarketBeat recorded 5 mentions for Aveanna Healthcare and 2 mentions for PACS Group. Aveanna Healthcare's average media sentiment score of 1.03 beat PACS Group's score of 0.40 indicating that Aveanna Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aveanna Healthcare	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PACS Group	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Aveanna Healthcare has higher earnings, but lower revenue than PACS Group. Aveanna Healthcare is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aveanna Healthcare	$2.43B	0.85	$225.03M	$1.18	8.01
PACS Group	$5.43B	1.36	$191.54M	$1.56	29.96

Summary

Aveanna Healthcare beats PACS Group on 11 of the 17 factors compared between the two stocks.

How does Aveanna Healthcare compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and Aveanna Healthcare (NASDAQ:AVAH) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability.

Billiontoone presently has a consensus target price of $126.00, suggesting a potential downside of 0.06%. Aveanna Healthcare has a consensus target price of $10.78, suggesting a potential upside of 14.05%. Given Aveanna Healthcare's stronger consensus rating and higher possible upside, analysts clearly believe Aveanna Healthcare is more favorable than Billiontoone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67

Aveanna Healthcare has higher revenue and earnings than Billiontoone. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$305.11M	19.00	$7.45M	$0.55	229.24
Aveanna Healthcare	$2.43B	0.85	$225.03M	$1.18	8.01

In the previous week, Aveanna Healthcare had 2 more articles in the media than Billiontoone. MarketBeat recorded 5 mentions for Aveanna Healthcare and 3 mentions for Billiontoone. Aveanna Healthcare's average media sentiment score of 1.03 beat Billiontoone's score of 0.63 indicating that Aveanna Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aveanna Healthcare	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Aveanna Healthcare has a net margin of 10.37% compared to Billiontoone's net margin of 0.00%. Aveanna Healthcare's return on equity of 124.68% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	N/A	N/A	N/A
Aveanna Healthcare	10.37%	124.68%	7.07%

88.0% of Aveanna Healthcare shares are held by institutional investors. 50.2% of Billiontoone shares are held by company insiders. Comparatively, 5.3% of Aveanna Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Aveanna Healthcare beats Billiontoone on 12 of the 15 factors compared between the two stocks.

How does Aveanna Healthcare compare to Celcuity?

Celcuity (NASDAQ:CELC) and Aveanna Healthcare (NASDAQ:AVAH) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, media sentiment, earnings, valuation, risk and analyst recommendations.

63.3% of Celcuity shares are held by institutional investors. Comparatively, 88.0% of Aveanna Healthcare shares are held by institutional investors. 13.3% of Celcuity shares are held by insiders. Comparatively, 5.3% of Aveanna Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Celcuity presently has a consensus price target of $155.18, indicating a potential upside of 87.83%. Aveanna Healthcare has a consensus price target of $10.78, indicating a potential upside of 14.05%. Given Celcuity's stronger consensus rating and higher probable upside, analysts plainly believe Celcuity is more favorable than Aveanna Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67

Celcuity has a beta of 0.16, suggesting that its stock price is 84% less volatile than the broader market. Comparatively, Aveanna Healthcare has a beta of 1.89, suggesting that its stock price is 89% more volatile than the broader market.

Aveanna Healthcare has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
Aveanna Healthcare	$2.43B	0.85	$225.03M	$1.18	8.01

In the previous week, Celcuity had 6 more articles in the media than Aveanna Healthcare. MarketBeat recorded 11 mentions for Celcuity and 5 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 1.03 beat Celcuity's score of -0.01 indicating that Aveanna Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	3 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Aveanna Healthcare	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Aveanna Healthcare has a net margin of 10.37% compared to Celcuity's net margin of 0.00%. Aveanna Healthcare's return on equity of 124.68% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
Aveanna Healthcare	10.37%	124.68%	7.07%

Summary

Aveanna Healthcare beats Celcuity on 11 of the 16 factors compared between the two stocks.

How does Aveanna Healthcare compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and Aveanna Healthcare (NASDAQ:AVAH) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

91.0% of Sotera Health shares are owned by institutional investors. Comparatively, 88.0% of Aveanna Healthcare shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by company insiders. Comparatively, 5.3% of Aveanna Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Aveanna Healthcare has higher revenue and earnings than Sotera Health. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.19B	4.16	$77.94M	$0.41	42.32
Aveanna Healthcare	$2.43B	0.85	$225.03M	$1.18	8.01

Sotera Health currently has a consensus target price of $20.25, suggesting a potential upside of 16.71%. Aveanna Healthcare has a consensus target price of $10.78, suggesting a potential upside of 14.05%. Given Sotera Health's stronger consensus rating and higher possible upside, equities research analysts clearly believe Sotera Health is more favorable than Aveanna Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67

In the previous week, Sotera Health had 2 more articles in the media than Aveanna Healthcare. MarketBeat recorded 7 mentions for Sotera Health and 5 mentions for Aveanna Healthcare. Sotera Health's average media sentiment score of 1.25 beat Aveanna Healthcare's score of 1.03 indicating that Sotera Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sotera Health	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aveanna Healthcare	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Sotera Health has a beta of 1.76, suggesting that its share price is 76% more volatile than the broader market. Comparatively, Aveanna Healthcare has a beta of 1.89, suggesting that its share price is 89% more volatile than the broader market.

Aveanna Healthcare has a net margin of 10.37% compared to Sotera Health's net margin of 9.91%. Aveanna Healthcare's return on equity of 124.68% beat Sotera Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	9.91%	39.73%	7.05%
Aveanna Healthcare	10.37%	124.68%	7.07%

Summary

Sotera Health beats Aveanna Healthcare on 9 of the 17 factors compared between the two stocks.

Get Aveanna Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AVAH vs. The Competition

Export

Metric	Aveanna Healthcare	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.98B	$6.42B	$6.88B	$12.26B
Dividend Yield	N/A	1.39%	2.67%	9.79%
P/E Ratio	8.01	41.10	27.00	23.71
Price / Sales	0.85	39.59	492.22	75.59
Price / Cash	13.17	19.09	50.54	59.64
Price / Book	10.16	3.90	10.28	6.07
Net Income	$225.03M	$218.81M	$3.60B	$331.84M
7 Day Performance	-2.48%	-0.84%	-1.25%	-1.53%
1 Month Performance	11.44%	9.79%	-0.35%	-2.46%
1 Year Performance	138.64%	38.70%	18.41%	13.66%

Aveanna Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AVAH Aveanna Healthcare	4.6329 of 5 stars	$9.45 +4.1%	$10.78 +14.1%	+139.8%	$1.98B	$2.43B	8.01	35,500	Positive News
HIMS Hims & Hers Health	2.9405 of 5 stars	$35.14 +2.2%	$30.70 -12.6%	-50.9%	$8.13B	$2.35B	N/A	2,442	Trending News Analyst Forecast Gap Up
PACS PACS Group	2.533 of 5 stars	$44.81 +3.6%	$50.60 +12.9%	+308.3%	$7.09B	$5.29B	28.73	47,455
BLLN Billiontoone	2.1446 of 5 stars	$124.87 +1.3%	$126.00 +0.9%	N/A	$5.74B	$305.11M	227.04	620
CELC Celcuity	3.1709 of 5 stars	$111.05 +7.0%	$152.09 +37.0%	+488.0%	$5.42B	N/A	N/A	40

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AVAH) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aveanna Healthcare (AVAH) Competitors

AVAH vs. HIMS, PACS, BLLN, CELC, and SHC

How does Aveanna Healthcare compare to Hims & Hers Health?

Summary

How does Aveanna Healthcare compare to PACS Group?

Summary

How does Aveanna Healthcare compare to Billiontoone?

Summary

How does Aveanna Healthcare compare to Celcuity?

Summary

How does Aveanna Healthcare compare to Sotera Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVAH vs. The Competition

Aveanna Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aveanna Healthcare (AVAH) Competitors

AVAH vs. HIMS, PACS, BLLN, CELC, and SHC

How does Aveanna Healthcare compare to Hims & Hers Health?

Does the media prefer AVAH or HIMS?

Do institutionals and insiders have more ownership in AVAH or HIMS?

Which has more risk and volatility, AVAH or HIMS?

Do analysts prefer AVAH or HIMS?

Which has higher valuation and earnings, AVAH or HIMS?

Is AVAH or HIMS more profitable?

Summary

How does Aveanna Healthcare compare to PACS Group?

Do insiders & institutionals hold more shares of AVAH or PACS?

Do analysts prefer AVAH or PACS?

Is AVAH or PACS more profitable?

Which has more risk & volatility, AVAH or PACS?

Does the media prefer AVAH or PACS?

Which has stronger valuation and earnings, AVAH or PACS?

Summary

How does Aveanna Healthcare compare to Billiontoone?

Do analysts rate BLLN or AVAH?

Which has better valuation & earnings, BLLN or AVAH?

Does the media prefer BLLN or AVAH?

Is BLLN or AVAH more profitable?

Do institutionals & insiders believe in BLLN or AVAH?

Summary

How does Aveanna Healthcare compare to Celcuity?

Do insiders and institutionals believe in CELC or AVAH?

Do analysts rate CELC or AVAH?

Which has more volatility & risk, CELC or AVAH?

Which has better earnings & valuation, CELC or AVAH?

Does the media prefer CELC or AVAH?

Is CELC or AVAH more profitable?

Summary

How does Aveanna Healthcare compare to Sotera Health?

Do insiders and institutionals hold more shares of SHC or AVAH?

Which has stronger valuation & earnings, SHC or AVAH?

Do analysts rate SHC or AVAH?

Does the media favor SHC or AVAH?

Which has more volatility & risk, SHC or AVAH?

Is SHC or AVAH more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVAH vs. The Competition

Aveanna Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools